What medicine does terminal liver cancer ache to take

Update Date: Source: Network

summary

I'm always tired all over this period of time. I don't feel strong. I don't have appetite to eat. I have a bad face. I'm yellow in wax. I still have nausea in the morning. I went to the hospital to check for liver cancer. Now the situation is stable. Do you know what medicine to take for advanced liver cancer? Let's talk about the pain of advanced liver cancer.

What medicine does terminal liver cancer ache to take

Drug 1: the society is progressing, so great changes have taken place in modern medical technology. There are more and more treatment methods for liver cancer. At present, there are many drugs for the early treatment of liver cancer, but very few of them have good effects. For example, xiangshen soft capsule, Ganfule capsule and other drugs on the market for the early treatment of liver cancer are anticancer drugs.

Drug 2: the mechanism of action of many targeted drugs is similar, and sorafenib is the first targeted drug for the treatment of liver cancer in clinical trials. In addition, sunitinib as a second-line drug, bevacizumab, erlotinib and other drugs have shown curative effect in phase II trials of liver cancer.

Drug 3: at present, some newly developed small molecule targeted drugs, such as androsterol, have been found to have a good therapeutic effect on liver cancer. This drug can improve the activity of AMPK, reduce the mitochondrial membrane potential and the content of mitochondria, so as to achieve the anti-inflammatory effect.

matters needing attention

For the elderly and frail patients, the use of surgical treatment of liver cancer will cause certain trauma to the body, and interventional treatment of liver cancer can be a good solution to this problem, the elderly and frail and some diseases can also be carried out, do not need general anesthesia, keep awake, because interventional treatment of liver cancer is simple and easy to operate, is a safe and reliable treatment, so it has won the favor of the majority of patients.